Chinese | English

  • Home
  • Service
    • FEASIBILITY STUDY
    • BE/PK/PD/PHASE I
    • PHASE II-IV/IIS/PMS
    • SUBJECT RECRUITMENT
    • SAS/STATISTICS ANALYSIS
    • MEDICAL WRITING/MONITOR
    • 3rd PARTY QA AUDIT
    • STAFF OUTSOURCING
    • EDC/DATABASE/DATA MANAGEMENT
    • REGULATORY AFFAIRS
    • MEDICAL BIGDATA & RWS
    • PHARMACOVIGILANCE
    • MARKETING RESEARCH/ACCESS
  • Client&feedback
    • OUR CLIENTS

    • CLIENTS'RECOGNITION

    • CASE STUDY

    • CLIENTS'FEEDBACK

    • PROJECTS COMPLETED

  • NEWS CENTER
    • COMPANY NEWS
    • PHOTOGRAPHY NEWS
  • Listing information
  • About us
    • ABOUT COMPANY
    • Management team
    • Corporate Advantages
    • DEVELOPMENT HISTORY
    • Video data

    • Contact us

News

  • COMPANY NEWS

  • PHOTOGRAPHY NEWS

Your current location:Home > News
  • Every successful enterprise will reborn from death.2019-03-14
  • Expanding, Prof. Meng visits shenzheng OSA group2019-03-13
  • If you don't realize it, you'll ruin the future2019-03-11
  • Ladies, Happy holidays2019-03-07
  • Explanation of drug discovery CRO2019-02-28
  • H&J will hold Q1 quarterly management Cycle Meeting in 20192019-02-27
  • Offices neat and orderly2019-02-26
  • What kind of CRC do sponsors like?2019-02-25
  • The leader of a pharmaceutical enterprise in Suzhou Industrial Park came to our company to discuss Business Corporation.2019-02-22
  • Every one of us should have the concept of "all-staff marketing"2019-02-21
  • Lantern Festival blessings2019-02-20
  • Graphical data of domestic clinical trials of cancer in 20182019-02-19
  • Corporate Culture-The Five Laws2019-02-15
  • Congratulations to H&J's Early Clinical Department for Its Fruitful Results in 20182019-02-14
上一页 12345 下一页
Han Bo Rui Qiang (Shanghai) Pharma-Tech Ltd,?H&J CRO International--New York LLC? ?Copyright H&J 2019